HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. It serves the biopharmaceutical companies, academic research centres, and molecular testing laboratories. Its proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A
Frequently Asked Questions
What is Market Cap of HTG Molecular Diagnostics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. HTG Molecular Diagnostics Inc market cap is $200.00.
What is the 52-week high for HTG Molecular Diagnostics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. HTG Molecular Diagnostics Inc 52 week high is $0.01 as of October 10, 2025.
What is the 52-week low for HTG Molecular Diagnostics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. HTG Molecular Diagnostics Inc 52 week low is $0.00 as of October 10, 2025.
What is HTG Molecular Diagnostics Inc stock price today?
HTG Molecular Diagnostics Inc stock price today is $0.0001.
What was HTG Molecular Diagnostics Inc stock price yesterday?
HTG Molecular Diagnostics Inc stock price yesterday was $0.0001.
What is the 50-day moving average of HTG Molecular Diagnostics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. HTG Molecular Diagnostics Inc 50-day moving average is $0.0001.